Description
Product Overview / 商品概要
Sennoside Tablets 12mg “Kunihiro” (センノシド錠12mg「クニヒロ」)
Generic: Sennoside / センノシド
Therapeutic Category: Laxative / 緩下剤
Manufactured by: Kokando Pharmaceutical Co., Ltd. / 皇漢堂製薬株式会社
Composition & Specification / 組成・規格
Active Ingredient: Sennoside 20mg (equivalent to 12mg as Sennoside A·B Calcium Salt) per tablet / センノシド20mg(センノシドA・Bカルシウム塩として12mg含有)
Additives: Microcrystalline cellulose, Partially pregelatinized starch, Light anhydrous silicic acid, Stearic acid, Hypromellose, Macrogol 6000, Sucrose, Talc, Titanium oxide, Acacia powder, Povidone, Carnauba wax, Ferric oxide / 結晶セルロース、部分アルファー化デンプン、軽質無水ケイ酸、ステアリン酸、ヒプロメロース、マクロゴール6000、白糖、タルク、酸化チタン、アラビアゴム末、ポビドン、カルナウバロウ、三二酸化鉄
Appearance: Yellowish dark red sugar-coated tablet. Diameter: 6.0mm, Thickness: 4.2mm, Weight: 120mg, Identification code: KSK220
外観: 帯黄暗赤色の糖衣錠。直径6.0mm、厚さ4.2mm、重量120mg、識別コード KSK220
Indications / 効能効果
EN: Constipation
JA: 便秘症
Dosage and Administration / 用法用量
EN: As Sennoside A·B (or its calcium salt), the usual adult dose is 12 to 24mg orally once daily at bedtime. For severe constipation, the dose may be increased to up to 48mg per dose. Adjust dose as appropriate based on age and symptoms.
JA: センノシドA・B(又はそのカルシウム塩)として、通常成人1日1回12~24mgを就寝前に経口投与する。高度の便秘には、1回48mgまで増量することができる。なお、年齢、症状により適宜増減する。
Contraindications / 禁忌
EN: Patients with a history of hypersensitivity to any component of this product or sennoside preparations; patients with suspected acute abdomen or spastic constipation; patients with severe impacted feces; patients with electrolyte imbalance (especially hypokalemia)
JA: 本剤の成分又はセンノシド製剤に過敏症の既往歴のある患者;急性腹症が疑われる患者、痙攣性便秘の患者;重症の硬結便のある患者;電解質失調(特に低カリウム血症)のある患者
Regulatory Information / 規制情報
Approval No.: 22500AMX01502000
Sales Started: February 2014 / 2014年2月
Classification Code: 872354
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年
Packaging / 包装
Main Package (for sale): 100 tablets (PTP: 10 tablets x 10) / 100錠(PTP:10錠×10)
Other Available Packages (by special order): 100 tablets (PTP: 10 tablets x 10), 1000 tablets (PTP: 10 tablets x 100), 1000 tablets (bulk)
Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.



![Ofloxacin Otic Solution 0.3% [CEO] (Ofloxacin Otic Solution CEO® / オフロキサシン耳科用液0.3%「CEO」)](https://jp-pharma.com/wp-content/uploads/2026/06/OFL-03-OTC_1200x1200-324x324.jpg)
Reviews
There are no reviews yet.